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ABSTRACT
Introduction: Many ocular diseases require
intravitreal injections of pharmacological
agents. Optimizing patients’ experiences
during injections is important to ensure
compliance and maintenance of quality of life.
The objective of this study was to identify
strategies to help alleviate discomfort during
intravitreal injections.
Methods: A cross-sectional study surveying 128
patients during clinic visits between 2014 and
2015 in two outpatient Retina Clinics (one
academic and one private). Patients receiving
an intravitreal injection(s) for any retinal
disorder were given a questionnaire with
10-yes/no responses for various potential
strategies. Responses were stratified by sex, age
(\30 years, 30–60 years, and [60 years) and
total number of prior injections (0–9
injections, 10–20 injections and [20
injections).
Results: A total of 128 patients were surveyed:
59 males, 41 females and 28 with no sex
specified. Our results identified four favorable
strategies as those receiving more than 50%
‘‘yes’’ votes. These included the presence of
technician/staff during the procedure, the use
of a neck pillow, a verbal warning before the
injection and performing injections in both
eyes on the same day. Other specific strategies
were identified for females, younger patients
and those with greatest experience. These
included: females preferred having their hand
held during injections (P = 0.001) and using a
stress ball (P = 0.000) when compared to males.
Stratifying by age, patients 30–60 years old
preferred having their hand held (P = 0.008)
and background music (P = 0.007). Stratifying
by prior injections, patients with [20 prior
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injections preferred having their hand held
(P = 0.001), using a stress ball (P = 0.021) and,
if necessary, having bilateral injections
performed the same day to improve comfort
(P = 0.037).
Conclusions: Having an extra staff member
present during the injection, having a neck
pillow, having a verbal warning prior to
injection and having both eyes injected on the
same day were indicated as favorable strategies
by over half of those surveyed. Further, specific
strategies were identified for females, younger
patients (30–60 years old) and those with
greatest experience ([20 injections).
Keywords: Comfort; Drug delivery; Intravitreal
injection; Patient; Quality improvement;
Retinal disease
INTRODUCTION
Intravitreal injections provide an effective
method for the administration of medications
in the treatment of many different ocular
diseases, including: age-related macular
degeneration, diabetic retinopathy, macular
edema, branch retinal vein occlusions, and
ophthalmic infections [1–5]. As the number of
conditions for which these injections are
employed continues to grow, so does the
frequency of their administration to patients
in the outpatient clinic setting. For example,
there was a 558-fold increase in the total
number of intravitreal injections performed in
Medicare patients, going from 4125 injections
in 2001 to 2,354,753 injections administered in
2012 alone [6].
Despite the safety and efficacy of intravitreal
injections, some patients may experience
significant discomfort and anxiety while
undergoing the procedure. Several studies have
explored pain-reducing strategies for
intravitreal injections. Two strategies
frequently studied in the literature are method
of anesthesia and needle gauge size. Choice of
anesthetic can be viewed as the most direct way
to reduce discomfort during an intravitreal
injection; however, no consensus has been
reached as to what type is superior overall.
Three methods commonly employed are topical
proparacaine drops, topical lidocaine gel and
sub-conjunctival lidocaine injections. A recent
study concluded that subconjunctival lidocaine
was most effective in preventing pain and eye
movement during injections [7]. Another study
found no statistical significance between many
various methods including lidocaine gel,
lidocaine-soaked pledget, and topical drops,
yet it advocated for the use of topical
proparacaine drops given their cost
effectiveness [8].
A similar trend can be seen when comparing
intravitreal needle gauge size and pain reduction.
One study that compared differences in pain
during the injection of dexamethasone
intravitreal implant (Ozurdex, Allergan) and
bevacizumab found that despite the larger needle
gauge and the tunneled injection technique
required to inject the dexamethasone
intravitreal implant, there was no significant
difference in reported pain levels between the
two injections [9]. After review of the current
literature, no consensus appears to exist
regarding intravitreal needle gauge size and the
amount of pain experienced by the patient. One
study showed no difference in pain score levels
between 30 and 27 gauge needles during
intravitreal injections [10]. Another study
comparing the two gauges found that 30 gauge
needles were associated with less pain in a subset
of patients studied, those less than 65 years old
[11]. One study analyzing 33 vs. 30 gauge needles
did not result in lower pain levels [12].
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Interestingly, this study identified factors other
than needle size that accounted for pain,
including: distress, expectation of pain and
discomfort, female gender and anticipating
negative consequences [12].
Thus, addressing pain-inducing factors
outside of the technical administration of
injections is an important concept that may
play a role in the reduction of discomfort in
many patients. Our study focuses on identifying
potential strategies other than type of
anesthesia or injection needle gauge size for
alleviating discomfort. As an added component,
we directly solicited patient input from their
own experience with intravitreal injections.
Very few studies have addressed alternative
methods to reduce discomfort. One such study
found that playing music decreased anxiety
during intravitreal injections [13]. In the
literature, the use of comfort strategies has
been explored in much more detail for
non-ocular procedures. For instance, evidence
suggests that the presence of additional people,
whether they are family members or additional
staff, may divert attention away from pain
during procedures such as venipuncture in
children [14]. Handholding has likewise been
shown to be a very effective coping strategy in
pain perception during procedures such as
blood draws, shunt placements, and peripheral
chemotherapy [15]. Stress balls have been
shown to be effective in reducing pain during
outpatient surgeries such as endovenous
thermal ablation and phlebectomies of
varicose veins [16]. Physical comfort can
reduce patient anxiety and stress as well as
pain during peripheral intravenous
cannulation, which led us to infer that
providing patients with a neck pillow might
be useful for intravitreal injections [17]. Use of a
verbal warning was also investigated, but was
not found to be very helpful in intravenous
cannulation [18]. The goal of this study was to
incorporate and evaluate strategies previously
proven to minimize discomfort in several minor
surgical procedures as well as to identify new
strategies that may increase comfort in patients
receiving repeat intravitreal injections.
METHODS
This study was conducted at the University of
Minnesota, Department of Ophthalmology
Retina Clinic and at a private retina clinic, the
Edina Retina Consultants. This prospective,
survey-based study was approved by the
Institutional Review Board (IRB) of the
University of Minnesota. This study is Health
Insurance Portability and Accountability Act
(HIPAA) compliant, and informed consent was
obtained by all participants. This study adheres
to the tenets of the Declaration of Helsinki. The
selection criteria included patients who were
undergoing current treatment with intravitreal
injections or who were going to receive their
first injection at that visit. The survey was given
to the patient on the same day they were
receiving their injection. In our study, the
anesthetic patients received varied. The
majority of our patients received topical
proparacaine drops only; the next most
common anesthetic was lidocaine jelly,
followed by subconjunctival lidocaine.
Participants were administered a ten
question survey where they were prompted to
indicate their preferences (by checking ‘‘yes’’ or
‘‘no’’) for or against potential strategies to
improve comfort during their intravitreal
injection(s). The survey also included a section
where patients could write in any other
suggestions they had regarding the process of
care during intravitreal injections. The survey
also recorded patient age, sex and number of
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previous number of injections (given
pre-selected ranges to choose from). Below is
the list of questions included in the survey.
1. Having the exam room lights dimmed as
much as possible.
2. Having a family member, friend, or
significant other present during the
injection.
3. Having a technician or staff member, in
addition to the physician, present during
the injection.
4. Having someone hold your hand during
the injection.
5. Having a stress ball to hold during the
injection.
6. Having music played in the background
during the injection.
7. Having a pillow placed under neck.
8. Having a verbal warning or notice given
just prior to the injection.
9. If both the eyes need to be injected, would
you prefer them both to be injected on the
same day?
10. If both the eyes need to be injected, would
you prefer them both to be injected on
different days?
This is an observational study where only
limited descriptive analysis was performed.
Qualitative statistical analysis was performed
using IBM SPSS 21 Statistics software (Armonk,
NY, USA). Stratification was done using
Chi-squared test and Pearson coefficients.
Results were measured in percentage of
patients who indicated ‘‘yes’’ or ‘‘no’’ to each
individual strategy. We defined favorable
strategies to be those for which more
than 50% of patients indicated ‘‘yes’’ as a
response.
RESULTS
A total of 128 patients completed the
questionnaire. The questionnaire included
responses from 59 males, 41 females and 28
patients with no sex indicated. Forty-three
patients had previously received 0–9
injections, 20 patients had received 10–20
injections, 43 patients had received more than
20 injections, and 22 patients with no
specification. Of those surveyed, none were
\30 years old, 5 patients were between the ages
of 30–60, 78 patients were[60 years old and 45
patients were unspecified. Patients listed their
diagnosis requiring injection(s) as follows: 85
reported macular degeneration, 7 reported
diabetic retinopathy, 2 reported
histoplasmosis, 2 reported macular edema, 1
reported Best disease, and 25 did not specify a
diagnosis. Only one diagnosis was listed for
each patient.
Figure 1 lists the percentage of subjects that
voted ‘‘yes’’ for each strategy; we defined
favorable strategies as those receiving more
than 50% ‘‘yes’’ votes. Favorable strategies
included the presence of Tech/Staff during the
procedure, the use of a pillow, a verbal warning
before the injection and performing injections
in both eyes on the same day.
The responses revealed significant
differences when stratified by sex, age, and
number of total injections received. Stratifying
by sex (Table 1), females reported statistically
significant preference for hand holding
(P = 0.001) and using a stress ball (P = 0.000)
when compared to males. Stratifying by age
(Table 2), patients 30–60 years old reported
statistically significant preference for hand
holding (P = 0.008) and having background
music (P = 0.007). Stratifying by the number
of prior injections (Table 3), patients who had
received [20 injections reported statistically
significant preferences for hand holding
(P = 0.001), using a stress ball (P = 0.021), and,
if necessary, having bilateral injections
performed the same day (P = 0.037).
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Our survey also included a section in which
patients could write in their own suggestions.
Those that were commonly repeated are listed
below:
1. Giving the injection quickly (10 patients).
2. Thoroughly numbing the eye prior to
injection (4 patients).
3. Thorough eye flushing after injection (3
patients).
4. Minimal use of Betadine (just on eyelashes
when eye is closed) (2 patients).
DISCUSSION
Overall, tabulation of our patients’ preferences
indicated four different strategies were favorable
in increasing comfort during intravitreal
injections. The most preferred strategy overall
was having both eyes injected (69.5% of
patients, Fig. 1) on the same day if bilateral
injections were indicated. We found this
surprising, given the informed consent process
patients undergo prior to receiving an injection.
From this, it can be inferred that patients
understand the theoretical increased risk in
having both eyes injected on the same day.
This strong preference for same-day bilateral
injections suggests that patients would rather
Fig. 1 Illustrates patients’ preference to each of the individual strategies surveyed. Survey responses were given in a ‘‘yes’’ or
‘‘no’’ format. X-axis represents each proposed strategy and y-axis refers to the percentage of patients’ responses








Light dimmed 32.8 52.5 0.051
Family/friend 39.7 29.3 0.287
Tech/staff 44.1 61.5 0.090
Hand held 27.1 61.0 0.001
Stress ball 8.5 41.5 0.000
Music 32.2 43.9 0.233
Pillow 61.0 68.3 0.456
Verbal warning 54.2 73.2 0.055
Same day 71.2 63.4 0.413
Different day 30.5 36.6 0.525
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accept the increased risk over the
inconvenience of a return visit for injection of
the opposite eye. This speaks to the burden on
patients’ lifestyle of having periodic eye
injections.
Other favorable strategies, preferred by[50%
of patients surveyed, such as having an
additional staff member or technician present
in the room, in addition to the treating
physician, a pillow placed underneath their
head during the injection and verbal warning
or count down prior to the injection, confirmed
what had been previously reported in the
literature in other non-ophthalmological
studies related to minimize patient’s
discomfort [13–18].
Interestingly, when stratified by age, sex, and
number of injections, common findings were
observed in all three categories. Specifically,
females, patients between 30 and 60 years old
and those who had received [20 injections all
preferred having their hand held during the
injection. A stress ball was a preferred strategy
amongst females and those patients who had
undergone over 20 previous injections. Younger
patients (30–60 years old) preferred having
background music playing during the injection.
The clinical significance of these results is to
demonstrate that different strategies can be
tailored to certain patients based on age, sex
and number of prior injections.
Patients with the most experience with
injections ([20 injections) preferred having
Table 2 Positive preferences for speciﬁc strategies







Light dimmed 80 39.5 0.075
Family/friend 40 35.1 0.823
Tech/staff 75 49.4 0.317
Hand held 100 39.7 0.008
Stress ball 40 21.8 0.348
Music 100 38.5 0.007
Pillow 100 67.9 0.130
Verbal warning 100 59.0 0.068
Same day 60 69.2 0.666
Different day 40 32.1 0.713









Light dimmed 45.2 30 38.1 0.504
Family/friend 35.7 40 30.2 0.725
Tech/staff 54.8 45 57.1 0.661
Hand held 23.3 50 62.8 0.001
Stress ball 16.3 10 37.2 0.021
Music 41.9 30 30.2 0.463
Pillow 65.1 75 48.8 0.101
Verbal warning 62.8 70 53.5 0.421
Same day 55.8 70 81.4 0.037
Different day 44.2 30 20.9 0.068
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both eyes injected on the same day in
comparison with those who had received fewer
injections. It may be inferred that patients
become more comfortable with these injections
over time. As patients have successful injections
with minimal to no complications, they may
begin to feel more comfortable taking the risk of
bilateral same-day injections in exchange for the
benefit of reducing their number of clinic visits.
The demographics of our study are closely in
line with those of the RVS Update Committee
Database, where 93.9% were white, 67% female,
and 77% over the age of 75 [6]. We feel this gives
additional value to the strategies identified since
they represent the patient population that
frequently receive intravitreal injections.
Our goal moving forward is to implement the
four strategies that were preferred by [50% of
patients surveyed in our outpatient clinical
practice. Some of these strategies have already
been implemented by our retina specialists.
Moreover, they have acknowledged a positive
response by their patients, noting that by
identifying patients’ personal preferences they
have increased overall patient satisfaction with
their eye care.
Future studies include increasing the number
of patients surveyed, especially those in the
younger age range, having a more equal
representation of males and females and also
increasing the number of patients in the 10–20
injections group. The main limitation of the
study is the lack of a post-implementation
survey in a randomized controlled trial to
address patient’s satisfaction and to confirm
the efficacy of these strategies.
CONCLUSION
Our study identified four main strategies that
increased comfort in patients receiving
intravitreal injections: same-day bilateral
injection, when indicated, the presence of an
extra staff member during the injection, the
placement of a pillow under their neck and a
verbal warning immediately before injection.
Additional specific strategies were identified for
females, younger patients (30–60 years old) and
those with greatest experience ([20 injections).
As the number of indications for intravitreal
injections continues to expand, so too does the
frequency of their administration. We are
hopeful that the implementation of strategies
to minimize patient discomfort can contribute
to increased compliance with intravitreal
injections and thus reduce the risk of further
vision loss.
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